NCT05911295 2026-04-07Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Seagen Inc.Phase 3 Active not recruiting412 enrolled
NCT07474064 2026-03-17Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBCSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Not yet recruiting146 enrolled